Duocarmycin TM is a potent synthetic antibiotic and DNA-binding agent classified as a topoisomerase inhibitor, primarily utilized in preclinical research for its efficacy in targeted cancer therapy, particularly… Read more












Duocarmycin TM is a potent synthetic antibiotic and DNA-binding agent classified as a topoisomerase inhibitor, primarily utilized in preclinical research for its efficacy in targeted cancer therapy, particularly when conjugated to antibodies. This category encompasses a range of high-quality reference standards essential for pharmaceutical laboratories engaged in drug development and quality control. Researchers rely on these compounds—including specific impurities, metabolites, and related analogues such as Duocarmycin MA and MB—to perform precise impurity profiling and rigorous analytical method validation. By utilizing these well-characterized materials, laboratories ensure the accuracy of assays designed to monitor stability, metabolic pathways, and structural integrity during the development of next-generation antibody-drug conjugates. Access to these specialized reagents supports the development of robust analytical protocols necessary for characterizing the complex profiles of these powerful, DNA-intercalating active pharmaceutical ingredients.